Hemorheological parameters as independent predictors of venous thromboembolism

Clinical Hemorheology and Microcirculation

Volumn 53, Issue 1-2, 2013, Pages 131-141

  Vayá, Amparo ^a   Suescun, Marta ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

cardiovascular risk factors; Deep vein thrombosis; hemorheology

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DYSFIBRINOGENEMIA; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; ERYTHROCYTE AGGREGATION; GENE MUTATION; GENETIC RISK; HEMATOCRIT; HUMAN; HYPERCOAGULABILITY; HYPERLIPIDEMIA; HYPERTENSION; METABOLIC SYNDROME X; MYELOMA; OBESITY; PERTHES DISEASE; POLYCYTHEMIA VERA; PREDICTIVE VALUE; SMOKING; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

DYSLIPIDEMIAS; HEMATOCRIT; HEMORHEOLOGY; HUMANS; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84872977638     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1581     Document Type: Article

References (93)

1. M. Abdollahi, M. Cushman and F.R. Rosendaal, Obesity: Risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use, Thromb Haemost 89 (2003), 493-498.
2. W. Ageno, C. Becattini, T. Brighton, R. Selby and P.W. Kamphuisen, Cardiovascular risk factors and venous thromboembolism: A meta-analysis, Circulation 117 (2008), 93-102.
3. W. Ageno, P. Prandoni, E. Romualdi, et al., Metabolic syndrome and the risk of venous thrombosis: A case-control study, J Thromb Haemost 4 (2006), 1914-1918.
4. E. Alt, S. Banyai, M. Banyai and R. Koppensteiner, Blood rheology in deep venous thrombosis - relation to persistent and transient risk factors, Thromb Res 107 (2002), 101-107.
5. R. Balendra, A. Rumley, M. Orr, S. Lennie, P. Mc Coll and G. Lowe, Blood lipids, coagulation, fibrinonolysis and rheology in spontaneous proven deep vein thrombosis, Brit Med J 77 (1991), 83.
6. O.K. Baskurt and H.J. Meiselman, Blood rheology and hemodynamics, Seminars Thromb Hemost 29 (2003), 435-450.
7. R.M. Bertina, Elevated clotting factor levels and venous thrombosis, Pathophysiol Haemost Thromb 33 (2004), 399-400.
8. R.M. Bertina, B.P. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, et al., Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature 369 (1994), 64-67.
9. K.H. Borch, S.K. Brækkan, E.B. Mathiesen, I. Njølstad, T. Wilsgaard, J. Størmer and J.B. Hansen, Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: The Tromsø study, Journal of Thromb and Haemost 7 (2009), 739-745.
10. S.K. Braekkan, E.B. Mathiesen, I. Njolstad, T.Wilsgaard and J.B. Hansen, Hematocrit and risk of venous thromboembolism in a general population. The Tromsø study, Haematologica 95 (2010), 270-275.
11. E.G. Brooks, W. Trotman, M.P. Wadsworth, D.J. Taatjes, M.F. Evans, F.P. Ittleman, P.W. Callas, C.T. Esmon and E.G. Bovill, Valves of the deep venous system: An overlooked risk factor, Blood 114 (2009), 1276-1279.
12. J.F. Brun, I. Aloulou and E. Varlet-Marie, Hemorheological aspects of the metabolic syndrome: Markers of insulin resistance, obesity or hyperinsulinemia? Clin Hemorheol Microcirc 30 (2004), 203-209.
13. M. Cabel, H.J. Meiselman, A.S. Popel and P.C. Johnson, Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle, Am J Physiol 272 (1997), 1020-1032.
14. H. Cam, K. P?us?uroglu, A. Aydin and M. Ercan, Effects of hemorheological factors on the development of hypertension in diabetic children, J Trop Pediatr 49 (2003), 164-167.
15. A. Chabanel, H. Horellou, J. Conard, et al., Red blood cell aggregability in patients with a history of leg vein thrombosis: Influence of post-thrombotic treatment, Brit J Haematol 88 (1994), 174-179.
16. S. Chien, Rheology in the microcirculation in normal and low flow states, Adv Shock Res 8 (1982), 71-80.
17. Z. Dabrowski, A.J. Dybowicz, A. Marchewka, A. Telegĺow, A. Skotnicki, A. Zdunczyk, P. Aleksander and K. Filar-Mierzwa, Elongation index of erythrocytes, study of activity of chosen erythrocyte enzymes, and the levels of glutathione, malonyldialdehyde in polycythemia vera (PV), Clin Hemorheol Microcirc 47 (2011), 169-176.
18. K.A. Darvall, R.C. Sam, S.H. Silverman, A.W. Bradbury and D.J. Adam, Obesity and thrombosis, Eur J Vasc Endovasc Surg 33 (2007), 223-233.
19. F. Dentali, A. Squizzato andW. Ageno, The metabolic syndrome as a risk factor for venous and arterial thrombosis, Semin Thromb Hemost 35 (2009), 451-457.
20. D.R. Faber, P.G. de Groot and F.L. Visseren, Role of adipose tissue in haemostasis, coagulation and fibrinolysis, Obes Rev 10 (2009), 554-563.
21. F.J. Fowkes, J.F. Price and F.G. Fowkes, Incidence of diagnosed deep vein thrombosis in the general population: Systematic review, Eur J Vasc Endovasc Surg 25 (2003), 1-5.
22. A. Gaarder, J. Jonsen, S. Laland, A. Hellem and P.A. Owren, Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets, Nature 192 (1961), 531-532.
23. S.Z. Goldhaber, D.D. Savage, R.J. Garrison, et al., Risk factor for pulmonary embolism. The Framingham Study. Am J Med 74 (1983), 1023-1028.
24. S.Z. Goldhaber, F. Grodstein, M.J. Stampfer, et al., A prospective study of risk factors for pulmonary embolism in women, JAMA 277 (1997), 642-645.
25. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith, J.A. Spertus Jr and F. Costa, Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: Executive Summary, Circulation 112 (2005), 2735-2752.
26. F. Harding and M.H. Knisely, Settling of sludge in human patients; a contribution to be biophysics of disease, Angiology 9 (1958), 317-341.
27. J.A. Heit, C.L. Leibson, A.A. Ashrani, T.M. Petterson, K.R. Bailey and L.J. Melton III, Is diabetes mellitus an independent risk factor for venous thromboembolism?:Apopulation-based case-control study, Arterioscler Thromb Vasc Biol 29 (2009), 1399-1405.
28. A.G. Holst, G. Jensen and E. Prescott, Risk factors for venous thromboembolism: Results from the Copenhagen City Heart Study, Circulation 121 (2010), 1896-1903.
29. M.K. Horne 3rd, A.M. Cullinane, P.K. Merryman and E.K. Hoddeson, The effect of red blood cells on thrombin generation, Br J Haematol 133 (2006), 403-408.
30. C. Irace, F. Scavelli, C. Carallo, R. Serra and A. Gnasso, Plasma and blood viscosity in metabolic syndrome, Nutr Metabol Cardiovasc Dis 19 (2009), 476-480.
31. T. Kawasaki, J. Kambayashi, H. Ariyoshi, M. Sakon, E. Suehisa and M. Monden, Hypercholesterolemia as a risk factor for deep vein thrombosis, Thromb Res 88 (1997), 67-73.
32. W. Koenig, M. Sund, E. Ernst, W. Mraz, V. Hombach and U. Keil, Association between rheology and components of lipoproteins in human blood. Results from the MONICA project, Circulation 85 (1992), 2197-2204.
33. W. Koenig, Fibrin(ogen) in cardiovascular disease: An update, Thromb Haemost 89 (2003), 601-609.
34. R. Koppensteiner, S. Hofmann, M. Atteneder, et al., Blood rheology in acute deep venous thrombosis. Follow up to one year after the acute event under conventional anticoagulant treatment. Clin Hemorheol Microcirc 12 (1992), 495.
35. T. Koster, F.R. Rosendaal, P.H. Reitsma, P.A. Van Der Velden, E. Bri?et and J.P. Vandenbroucke, Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - the Leiden Thrombophilia Study (LETS), Thromb Haemost 71 (1994), 719-722.
36. E. Krieger,B. van Der Loo, B.R. Amann-Vesti,V. Rousson and R.Koppensteiner, C-reactive protein and red cell aggregation correlate with late venous function after acute deep venous thrombosis, J Vasc Surg 40 (2004), 644-649.
37. D. Lane and P. Grant, Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease, Blood 95 (2000), 1517-1532.
38. W.M. Lijfering, S.C. Christiansen and I.A. Naess, et al., The risk of venous thrombosis related to increase in body mass index is mediated by factor VIII induced APC resistance, Blood 114 (2009), 453.
39. H.H. Lipowsky, Microvascular rheology and hemodynamics. Microcirculation 12 (2005), 5-15.
40. G. Lippi, G. Brocco, F. Manzato and G. Guidi, Relationship between venous thromboembolism and lipid or lipoprotein disorders, Thromb Res 95 (1999), 353-354.
41. I. Martinelli and V. De Stefano, Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review. Thromb Haemost 103 (2010), 1136-1144.
42. M.D. McColl, N. Sattar, J. Ellison, et al., Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism, Blood Coagul Fibrinolysis 11 (2000), 225-229.
43. F. Michota, Venous Thromboembolism: Epidemiology, characteristics, and consequences, Clin Cornestone 7 (2005), 8-15.
44. Y. Mira, A. Vaýa and M. Mart́inez, et al., Hemorheological alterations and hypercoagulable state in deep vein thrombosis, Clin Hemorheol Microcirc 19 (1998), 265-270.
45. I.A. Naess, S.C. Christiansen, P. Romundstad, S.C. Cannegieter, F.R. Rosendaal and J. Hammerstrøm, Incidence and mortality of venous thrombosis: A population-based study, J Thromb Haemost 5 (2007), 692-699.
46. G.B. Nash, T. Watts, C. Thornton and M. Barigou, Red cell aggregation as a factor influencing margination and adhesion of leukocytes and platelets, Clin Hemorheol Microcirc 39 (2008), 303-310.
47. L.H. Opie, Metabolic syndrome, Circulation 115 (2007), 32-35.
48. M.J. Pearson and H.H. Lipowsky, Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery, Am J Physiol Heart Circ Physiol 279 (2000), 1460-1471.
49. V. Petrauskiene, M. Falk, I.Waernbaum, M. Norberg and J.W. Eriksson, The risk of venous thromboembolism is markedly elevated in patients with diabetes, Diabetologia 48 (2005), 1017-1021.
50. E.R. Pomp, S. le Cessie, F.R. Rosendaal and C.J. Doggen, Risk of venous thrombosis: Obesity and its joint effect with oral contraceptive use and prothrombotic mutations, Br J Haematol 139 (2007), 289-296.
51. E.R. Pomp, F.R. Rosendaal and C.J. Doggen, Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use, Am J Hematol 83 (2008), 97-102.
52. S.R. Poort, F.R. Rosendaal, P.H. Reitsma and R.M. Bertina, A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood 88 (1996), 3698-3703.
53. P. Prandoni, E. Bernardi, A. Marchiori, A.W. Lensing, M.H. Prins, S.Villalta, P. Bagatella, D. Sartor,A. Piccioli, P. Simioni, A. Pagnan and A. Girolami, The long term clinical course of acute deep vein thrombosis of the arm: Prospective cohort study, BMJ 329 (2004), 484-485.
54. A. Pribush, L. Hatskelzon, D. Mazor, E. Katorza, D. Zilberman-Kravits and N. Meyerstein, The role of erythrocyte aggregation in the abnormal hemorheology of multiple myeloma patients, Clin Hemorheol Microcirc 34 (2006), 529-536.
55. J.G. Ray, E. lonn, Q. Yi, A. Rathe, P. Sheridan and C. Kearon, On behalf of the HOPE-2 investigators. Venous thromboembolism in association with features of the metabolic syndrome Q J Med 100 (2007), 679-684.
56. J.G. Ray and F.R. Rosendaal, The role of dyslipidemia and statins in venous thromboembolism, Curr Control Trials Cardiovasc Med 2 (2001), 165-170.
57. W.H. Reinhart, O. Lutolf, U.R. Nydegger, F. Mahler and P.W. Straub, Plasmapheresis for hyperviscosity syndrome in macroglobulinemiaWaldenstr?om and multiple myeloma: Influence on blood rheology and the microcirculation, J Lab Clin Med 119 (1992), 69-76.
58. W. Renner, L. Cichocki, A. Forjanics, H. Koppel, R. Gasser and E. Pilger, G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis, Eur J Clin Invest 32 (2002), 755-758.
59. F.R. Rosendaal, Venous thrombosis: A multicausal disease, Lancet 353 (1999), 1167-1173.
60. R.S. Rosenson and G.D. Lowe, Effects of lipids and lipoproteins on thrombosis and rheology, Atherosclerosis 140 (1998), 271-280.
61. R.S. Rosenson, S. Shott and C.C. Tangney, Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: Triglycerides and blood viscosity, Atherosclerosis 161 (2002), 433-439.
62. P. Saha, J. Humphries, B. Modarai, K. Mattock, M. Waltham, C.E. Evans, A. Ahmad, A.S. Patel, S. Premaratne, O.T. Lyons and A. Smith, Leukocytes and the natural history of deep vein thrombosis: Current concepts and future directions, Arterioscler Thromb Vasc Biol 31 (2011), 506-512.
63. D. Samocha-Bonet, R. Ben-Ami, I. Shapira, G. Shenkerman, S. Abu-Abeid, N. Stern, T. Mardi, T. Tulchinski, V. Deutsch, S. Yedgar, G. Barshtein and S. Berliner, Flow-resistant red blood cell aggregation in morbid obesity, Int J Obes Relat Metab Disord 28 (2004), 1528-1534.
64. M.T. Santos, J. Valles, A.J. Marcus, L.B. Safier, M.J. Broekman, N. Islam, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 87 (1992), 571-580.
65. A. Schreijer, P. Reitsma and S. Cannegieter, High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? Haematologica 95 (2010), 182-184.
66. M.T. Severinsen, S.R. Kristensen, S.P. Johnsen, C. Dethlefsen, A. Tjønneland and K. Overvad, Smoking and venous thromboembolism: A Danish follow-up study, J Thromb Haemost 7 (2009), 1297-1303.
67. S. Shimada, K. Hasegawa, H. Wada, S. Terashima, N. Satoh-Asahara, H. Yamakage, S. Kitaoka, M. Akao, A. Shimatsu and Y. Takahashi, High blood viscosity is closely associated with cigarette smoking and markedly reduced by smoking cessation, Circ J 75 (2011), 185-189.
68. M. Singh and S. Shin, Changes in erythrocyte aggregation and deformability in diabetes mellitus: A brief review, Indian J Exp Biol 47 (2009), 7-15.
69. E. Soĺa, A. Vaýa, M. Siḿo, A. Herńandez- Mijares, C. Morillas, F. Espa?na, A. Estelĺes and D. Corella, Fibrinogen, plasma viscosity and blood viscosity in obesity, Relationship with insulin resistance,Clin Hemorheol Microcirc 37 (2007), 309-318.
70. E. Soĺa, A. Vaýa, D. Corella, M.L. Santaolaria, F. Espa?na, A. Estelĺes and A. Herńandez-Mijares, Erythrocyte hyperaggregation in obesity: Determining factors and weight loss influence, Obesity 15 (2007), 2128-2134.
71. L.M. Steffen, M. Cushman, J.M. Peacock, S.R. Heckbert, D.R. Jacobs, W.D. Rosamond and A.R. Folsom, Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolisms Etiology (LITE), J Thromb Haemost 7 (2009), 746-751.
72. G.B. Thurston, Viscoelasticity of human blood, Biophys J 12 (1972), 1205-1217.
73. A.W. Tsai, M. Cushman, W.D. Rosamond, S.R. Heckbert, J.F. Polak and A.R. Folsom, Cardiovascular risk factors and venous thromboembolism incidence: The longitudinal investigation of thromboembolism etiology, Arch Intern Med 162 (2002), 1182-1189.
74. V. Van Hylckama and F.R. Rosendaal, High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly, J Thromb Haemost 1 (2003), 2677-2678.
75. A. Vaýa, M. Martinez Triguero, M. Romagnoli, M. Ĺopez, A. Ricart and D. Corella, Lack of association between hemorheological alterations and upper-extremity deep vein thrombosis, Clin Hemorheol Microcirc 41 (2009), 279-285.
76. A. Vaýa, Y. Mira, F. Ferrando, D. Corella and J. Aznar, Does obesity constitute a risk factor for upper-extremity deep vein thrombosis? Thromb Haemost 94 (2005), 228-230.
77. A. Vaýa, Y. Mira, F. Ferrando, M. Contreras, A. Estelles, F. Espa?na, D. Corella and J. Aznar, Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors, Br J Haematol 118 (2002), 255-259.
78. A. Vaýa, M. Mart́inez, R. Carmena and J. Aznar, Red blood cell aggregation and primary hyperlipoproteinemia, Thromb Res 72 (1993), 119-126.
79. A. Vaýa, M. Mart́inez Triguero, E. Ŕeganon, V. Vila, V. Mart́inez Sales, E. Soĺa, A. Herńandez Mijares and A. Ricart, Erythrocyte membrane composition in patients with primary hypercholesterolemia, Clin Hemorheol Microcirc 40 (2008), 289-294.
80. A. Vaýa, M. Mart́inez, J. Dalmau and J. Aznar, Hemorheological changes in children with polygenic hypercholesterolemia, Clin Hemorheol Microcirc 19 (1998), 259-262.
81. A. Vaýa, M. Mart́inez, M. Guilĺen, J. Dalmau and J. Aznar, Erythrocyte deformability in young familial hypercholesterolemics, Clin Hemorheol Microcirc 19 (1998), 43-48.
82. A. Vaýa, M.L. Mart́inez-Triguero, F. Espa?na, J.A. Todoĺi, E. Bonet and D. Corella, The metabolic syndrome and its individual components: Its association with venous thromboembolism in a Mediterranean Population, Metab Syndr Relat Disord 9 (2011), 197-201.
83. A. Vaýa, A. Herńandez-Mijares, E. Bonet, R. Sendra, E. Soĺa, R. Ṕerez, D. Corella and B. Laiz, Association between hemorheological alterations and metabolic syndrome, Clin Hemorheol Microcirc 49 (2011), 493-503.
84. A. Vaýa, A. Herńandez-Mijares, M. Suescun, E. Soĺa, R. Ćamara, M. Romagnoli, D. Bautista and B. Laiz, Metabolic alterations in morbid obesity. Influence on the haemorheological profile, Clin Hemorheol Microcirc 48 (2011), 247-255.
85. A. Vaýa, R. Ćamara, A. Herńadez-Mijares, M. Romagnoli, E. Soĺa, D. Corella and B. Laiz, Erythrocyte deformability in morbid obesity before bariatric surgery. Influence of abdominal obesity, Clin Hemorheol Microcirc 46 (2010), 313-320.
86. A. Vaýa, M. Mart́inez, J. Garcia, M. Labios and J. Aznar, Hemorheological alterations in mild essential hypertension, Thromb Res 66 (1992), 223-229.
87. A. Vaýa, Y. Mira, M. Mart́inez, P. Villa, F. Ferrando, A. Estelĺes, D. Corella and J. Aznar, Biological risk factors for deep vein thrombosis, Clinical Hemorheol Microcirc 26 (2002), 41-53.
88. A. Vaýa, C. Falćo, M. Siḿo, F. Ferrando, Y. Mira, J. Todoĺi, F. Espa?na and D. Corella, Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis, Thromb Haemost 98 (2007), 621-626.
89. T.W.Wakefield, D.D. Myers and P.K. Henke, Mechanisms of venous thrombosis and resolution, Arterioscler Thromb Vasc Biol 28 (2008), 387-391.
90. S.G. Wannamethee, G.D. Lowe, A.G. Shaper, A. Rumley, L. Lennon and P.H. Whincup, Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease, Eur Heart J 26 (2005), 1765-1773.
91. M. Wiewiora, L. Slowinska, M. Wylezol, M. Pardela and A. Kobielski, Rheological properties of erythrocytes in patients suffering from morbid obesity. Examination with LORCA device, Clin Hemorheol Microcirc 34 (2006), 499-506.
92. L. Zhang, K. Pu, S.Y. Zhang and W.Q. Ren, Blood rheological properties are strongly related to the metabolic syndrome in middle-aged Chinese, Int J Cardiol 112 (2006), 229-233.
93. R.F. Zwaal and A.J. Schroit, Pathophysiologic implications of membrane phospholipid asymmetry in blood cells, Blood 89 (1997), 1121-1132.